HomeVALN • NASDAQ
add
Valneva SE
Previous close
$9.54
Day range
$9.21 - $9.41
Year range
$3.62 - $12.25
Market cap
802.33M USD
Avg Volume
24.40K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 29.41M | -35.82% |
Operating expense | 15.56M | 13.89% |
Net income | -44.36M | -380.24% |
Net profit margin | -150.82 | -648.12% |
Earnings per share | -0.26 | -72.17% |
EBITDA | -31.96M | -326.31% |
Effective tax rate | -2.03% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 143.46M | -8.23% |
Total assets | 448.23M | -13.24% |
Total liabilities | 297.75M | -0.47% |
Total equity | 150.48M | — |
Shares outstanding | 181.05M | — |
Price to book | 11.49 | — |
Return on assets | -20.28% | — |
Return on capital | -25.59% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -44.36M | -380.24% |
Cash from operations | -17.44M | -66.39% |
Cash from investing | 197.00K | 101.28% |
Cash from financing | -556.00K | -101.07% |
Net change in cash | -17.84M | -171.60% |
Free cash flow | -16.25M | 39.99% |
About
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Founded
2013
Website
Employees
700
